EP 1139913 A4 20020911 - COMPOSITION AND FORMULATIONS AND THEIR USE AS NOCICEPTIC, ANTI-ANXIOLYTIC AND ANABOLIC AGENTS

Title (en)

COMPOSITION AND FORMULATIONS AND THEIR USE AS NOCICEPTIC, ANTI-ANXIOLYTIC AND ANABOLIC AGENTS

Title (de)

ZUSAMMENSETZUNGEN UND SUBSTANZEN SOWIE DEREN ANWENDUNG ALS NOCICEPTISCHE, ANTIANXIOLYTISCHE UND ANABOLISCHE WIRKSTOFFE

Title (fr)

COMPOSITION ET FORMULATIONS ET LEUR UTILISATION COMME NOCICEPTIFS, ANTI-ANXIOLYTIQUES ET ANABOLISANTS

Publication

EP 1139913 A4 20020911 (EN)

Application

EP 00904212 A 20000105

Priority

US 0000180 W 20000105
US 11477399 P 19990105

Abstract (en)

[origin: WO0040172A1] Composition and formulations comprising a first agent such as folinic acid, pharmaceutically acceptable salts thereof or mixtures thereof, and a second agent(s) such as analgesics, muscle relaxants, mood disorder agents, anti-inflammatories, anti-migraine agents, anti-emetics, diuretics, high protein composites, and the like. The products are suitable as nociceptics and for the treatment of wasting disorders, bulimia, anorexia nervosa, anxiety, irritability and other symptoms associated with Pre Menstrual Syndrome, as well as for administration either in conjunction with steroids or to compensate adenosine depletion and/or bizarre behavior or aggression common in steroid users.

IPC 1-7

A61K 31/519; A61K 31/5685; A61K 31/569; A61K 45/06; A61P 1/08; A61P 25/22

IPC 8 full level

A23L 1/30 (2006.01); A61K 9/02 (2006.01); A61K 9/08 (2006.01); A61K 9/10 (2006.01); A61K 9/12 (2006.01); A61K 9/14 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/167 (2006.01); A61K 31/192 (2006.01); A61K 31/519 (2006.01); A61K 31/60 (2006.01); A61K 45/00 (2006.01); A61K 45/06 (2006.01); A61K 47/06 (2006.01); A61K 47/10 (2006.01); A61K 47/26 (2006.01); A61K 47/34 (2006.01); A61K 47/42 (2006.01); A61K 47/46 (2006.01); A61P 1/04 (2006.01); A61P 1/08 (2006.01); A61P 1/10 (2006.01); A61P 3/02 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); A61P 9/06 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 15/00 (2006.01); A61P 15/16 (2006.01); A61P 15/18 (2006.01); A61P 17/02 (2006.01); A61P 17/12 (2006.01); A61P 17/14 (2006.01); A61P 19/02 (2006.01); A61P 21/02 (2006.01); A61P 25/04 (2006.01); A61P 25/18 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 37/00 (2006.01); A61P 43/00 (2006.01); C07D 475/04 (2006.01)

CPC (source: EP KR)

A61K 31/525 (2013.01 - KR); A61K 45/06 (2013.01 - EP); A61P 1/04 (2017.12 - EP); A61P 1/08 (2017.12 - EP); A61P 1/10 (2017.12 - EP); A61P 3/02 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/06 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/16 (2017.12 - EP); A61P 15/18 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 17/12 (2017.12 - EP); A61P 17/14 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 21/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)

Citation (search report)

[E] WO 0007566 A1 20000217 - EPIGENESIS PHARMACEUTICALS INC [US], et al
[X] WO 9625935 A1 19960829 - UNIV EAST CAROLINA [US], et al
[X] WO 9819690 A1 19980514 - BRISTOL MYERS SQUIBB CO [US]
[X] WO 9727764 A1 19970807 - UNIV SOUTH ALABAMA [US], et al
[X] EP 0388827 A1 19900926 - BIORESEARCH SPA [IT]
[X] FRENIA MAUREEN L ET AL: "Methanol inhalation toxicity.", ANNALS OF EMERGENCY MEDICINE, vol. 22, no. 12, 1993, pages 1919 - 1923, XP001080384, ISSN: 0196-0644
See references of WO 0040172A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0040172 A1 20000713; WO 0040172 B1 20001102; AU 2600000 A 20000724; BR 0007397 A 20011030; CA 2356368 A1 20000713; CN 1354640 A 20020619; EP 1139913 A1 20011010; EP 1139913 A4 20020911; IL 143644 A0 20020421; JP 2003523933 A 20030812; KR 20010089782 A 20011008

DOCDB simple family (application)

US 0000180 W 20000105; AU 2600000 A 20000105; BR 0007397 A 20000105; CA 2356368 A 20000105; CN 00802582 A 20000105; EP 00904212 A 20000105; IL 14364400 A 20000105; JP 2000591931 A 20000105; KR 20017008574 A 20010705